How to Get Alprostadil (Caverject/MUSE) in Wyoming

What Is Alprostadil and Why Is It Used for Erectile Dysfunction?

Alprostadil is a synthetic prostaglandin E1 (PGE1) analogue that produces penile erection by relaxing smooth muscle and dilating arterial vessels in the corpus cavernosum. For men who do not respond adequately to oral PDE5 inhibitors such as sildenafil or tadalafil, alprostadil is the most established second-line pharmacotherapy. The FDA-approved branded products are Caverject (Pfizer) for intracavernosal injection and MUSE (Meda Pharmaceuticals) for intraurethral delivery.

In the landmark 1996 NEJM trial by Linet and colleagues (N=683), intracavernosal alprostadil produced successful erections in 94% of injection attempts compared with 11% for placebo, with a significant dose-response relationship across the 2.5 to 20 mcg range [1]. A separate multi-center study published in NEJM the same year showed alprostadil produced erections sufficient for intercourse in approximately 65% of men in an at-home setting [2]. These figures represent the clinical benchmark cited in the FDA prescribing information for Caverject [3].

Erectile dysfunction affects roughly 30 million men in the United States, with prevalence increasing sharply after age 40, according to data from the National Institute of Diabetes and Digestive and Kidney Diseases [4]. Wyoming's rural geography means many men face significant travel barriers to in-person urology care, making telehealth prescribing particularly relevant.

Who Can Prescribe Alprostadil in Wyoming?

Any licensed prescriber with Wyoming DEA registration and active Wyoming state licensure may prescribe alprostadil. That includes physicians (MD/DO), physician assistants (PA-C), and nurse practitioners with prescriptive authority under Wyoming statute Title 33.

Wyoming follows a collaborative practice model for advanced practice providers. Nurse practitioners in Wyoming operate under a reduced-supervision framework that grants independent prescriptive authority once licensure requirements are met, meaning an NP working for a telehealth platform can prescribe alprostadil without a co-signing physician for each encounter.

Urologists, primary care physicians, and internal medicine providers all commonly prescribe alprostadil. Endocrinologists also prescribe it when ED accompanies poorly controlled diabetes or hypogonadism. The American Urological Association (AUA) guideline on ED recommends offering intracavernosal vasoactive agents to men who fail or cannot tolerate PDE5 inhibitors [5]. The AUA guideline states: "Intracavernosal injection therapy with vasoactive agents is recommended as a second-line therapy for ED in men for whom first-line therapy is contraindicated, ineffective, or not desired."

How to Get a Prescription in Wyoming: Step by Step

Getting alprostadil in Wyoming involves four steps: a clinical evaluation, prescription issuance, pharmacy selection, and injection training.

Step 1. Schedule a telehealth or in-person visit. A full sexual health consultation typically takes 20 to 30 minutes. The provider will review your ED history, comorbidities (especially cardiovascular disease, diabetes, and hypogonadism), current medications, and any prior PDE5 inhibitor use. Wyoming's telehealth parity law (Wyoming Statutes 26-15-140) requires most private insurers to cover telehealth visits on par with in-person encounters, so check whether your consultation fee is reimbursable [6].

Step 2. Baseline labs. Most providers order a panel before writing the first prescription. The Endocrine Society clinical practice guideline on male hypogonadism recommends measuring total testosterone (with free testosterone if SHBG is abnormal), as untreated hypogonadism reduces response to alprostadil [7]. A standard pre-treatment panel includes total and free testosterone (morning draw), HbA1c, fasting lipids, CBC, and a comprehensive metabolic panel. Penile Doppler ultrasound may be requested by urologists to characterize vascular etiology, though it is not required before a first prescription.

Step 3. Prescription issuance. Alprostadil is Schedule V in some states but is not federally scheduled; Wyoming does not place it on its controlled substance schedule, so e-prescribing follows standard non-controlled rules. The provider sends the prescription electronically to your preferred pharmacy.

Step 4. Injection training. Caverject requires self-injection into the lateral corpus cavernosum. The FDA label mandates that the first injection be administered in a clinical setting, with the patient observed for at least 30 minutes for priapism or hypotension [3]. Telehealth providers typically coordinate this with a local urgent care, primary care office, or pharmacy that offers injection training, or they schedule a brief in-person visit for the first dose demonstration.

Telehealth Providers in Wyoming Prescribing Alprostadil

Telehealth prescribing of alprostadil is explicitly permitted in Wyoming. The Wyoming Board of Medicine recognizes that a valid patient-physician relationship can be established via synchronous audio-video consultation. No prior in-person visit is required under current Wyoming telemedicine regulations [8].

Several national telehealth platforms are licensed to prescribe in Wyoming and carry alprostadil on their formulary. When evaluating a platform, confirm three things: the provider holds an active Wyoming medical license, the platform uses a synchronous video visit (not just an asynchronous questionnaire) to satisfy Wyoming's prescribing standard, and the pharmacy partner is licensed to ship to Wyoming ZIP codes. Asynchronous-only platforms may not meet Wyoming Board of Medicine requirements for establishing a new patient-physician relationship for a prescription medication.

HealthRX providers conduct synchronous video consultations and can issue Wyoming alprostadil prescriptions the same day for eligible patients. After the visit, the prescription routes to a partner pharmacy with typical delivery in 3, 5 business days.

Pharmacy Options in Wyoming: Branded vs. Compounded Alprostadil

Wyoming residents have three main pharmacy pathways for filling an alprostadil prescription.

Branded retail pharmacies. Caverject Impulse (Pfizer) and MUSE are available at major chain pharmacies including Walgreens, Walmart, and Smith's in Cheyenne, Casper, Laramie, Gillette, and Rock Springs, though stock is limited at smaller rural locations. Cash price for a Caverject 10 mcg dual-chamber syringe pack (6 syringes) runs approximately $350, $500 without insurance.

503A compounding pharmacies. Wyoming permits licensed 503A pharmacies to compound and ship alprostadil to Wyoming patients under a valid patient-specific prescription. A 503A pharmacy compounds for individual prescriptions rather than in bulk; each preparation is patient-specific, which is required for interstate shipment under federal law [9]. Compounded alprostadil injections, often formulated at concentrations of 10 to 40 mcg/mL, can cost 40 to 60% less than branded Caverject. Verify that the compounding pharmacy is licensed in both its home state and holds a valid non-resident pharmacy permit from the Wyoming Board of Pharmacy before ordering [10].

Mail-order specialty pharmacy. Several specialty pharmacies (Walgreens Specialty, Maxor) ship temperature-sensitive injectables to Wyoming addresses. Caverject requires refrigeration below 25°C (77°F); the pharmacy should use validated cold-chain shipping for summer deliveries in Wyoming, where ambient temperatures in Casper can exceed 95°F in July.

According to the FDA's guidance on compounding under section 503A of the Federal Food, Drug, and Cosmetic Act: "A licensed pharmacist or physician may compound a drug product if... it is compounded for an identified individual patient based on the receipt of a valid prescription order" [9].

Does Wyoming Medicaid Cover Alprostadil?

Wyoming Medicaid does not cover alprostadil for erectile dysfunction. ED is classified as a lifestyle condition under Wyoming Medicaid's excluded benefit list, consistent with the federal Medicaid statute which allows states to exclude drugs for conditions the state deems non-essential [11].

Private insurance coverage varies widely. Some plans cover Caverject under a specialty tier when prior authorization (PA) is obtained. A typical PA submission for alprostadil in Wyoming requires: documentation of at least two failed trials of oral PDE5 inhibitors (with dates, doses, and duration), a diagnosis of organic or mixed-etiology ED confirmed by a licensed provider, lab results ruling out uncorrected hypogonadism, and a note that the patient cannot use PDE5 inhibitors due to cardiovascular contraindication or concurrent nitrate use [12].

The American Diabetes Association Standards of Care 2024 notes that ED occurs in 35 to 75% of men with diabetes and recommends addressing it as part of comprehensive diabetes management, which may support the medical necessity argument in a PA submission [13].

Alprostadil Dosing: Caverject vs. MUSE

The two delivery routes have different dose ranges, onset times, and efficacy profiles.

Caverject (intracavernosal injection). Starting dose is 2.5 mcg for men with neurogenic ED and 2.5 to 5 mcg for vasculogenic ED. The provider titrates upward in 2.5 to 5 mcg increments at the training visit until an erection lasting 30 to 60 minutes is achieved. Maximum single dose is 60 mcg (vasculogenic) or 20 mcg (neurogenic). Onset is typically 5 to 20 minutes; duration 30 to 60 minutes. Injection frequency should not exceed once daily or three times per week [3].

MUSE (intraurethral suppository). Starting dose is 125 mcg or 250 mcg. Effective dose range is 125, 1 to 000 mcg. Onset is 5 to 10 minutes; efficacy for intercourse in published trials is approximately 43% vs. 65% for intracavernosal injection [14]. MUSE requires urethral voiding immediately before insertion and a brief walking period to distribute the suppository.

A 2020 meta-analysis in the Journal of Sexual Medicine (N=2,477 across 14 RCTs) confirmed that intracavernosal alprostadil produces significantly higher rates of erection sufficient for intercourse compared with intraurethral delivery (pooled odds ratio 2.41 to 95% CI 1.87, 3.10, P<0.001) [15].

Safety Considerations and Contraindications

Alprostadil is contraindicated in men with a known hypersensitivity to prostaglandin E1, those with conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia), and those with anatomical penile deformity (including untreated Peyronie's disease with severe curvature) [3].

The most clinically significant adverse event is priapism, defined as an erection persisting beyond four hours. The Linet 1996 NEJM trial reported a priapism rate of 1.3% with in-office titration [1]. Patients must be instructed to seek emergency care if erection persists beyond four hours, as corporal ischemia can occur within six hours. The AUA priapism guideline recommends corporal aspiration followed by intracavernosal phenylephrine as first-line management [16].

Penile pain occurs in approximately 37% of patients in the Linet trial, is generally mild-to-moderate, and tends to decrease with repeated use [1]. Hematoma at the injection site is reported in roughly 3% of injections.

Cardiovascular monitoring is appropriate because alprostadil can produce mild systemic hypotension at higher doses. Men with unstable angina, recent myocardial infarction (within 6 months), or severe hypotension (systolic BP <90 mmHg) should not use alprostadil until cardiac status is stabilized, as recommended by the Princeton Consensus (Third) Guidelines on sexual activity and cardiovascular disease [17].

Transferring an Existing Alprostadil Prescription to Wyoming

Men relocating to Wyoming with an existing alprostadil prescription from another state can transfer it to a Wyoming-licensed pharmacy. Non-controlled drug prescriptions can be transferred between pharmacies in most states, though individual pharmacies may require a new prescription from a Wyoming-licensed provider after the first fill.

If you are moving to Wyoming and your original prescriber is not licensed there, a telehealth visit with a Wyoming-licensed provider for a new prescription is the cleanest option. The new provider will review your current dose, any prior adverse events, and update labs if the prior panel is older than 12 months. Testosterone should be re-checked annually in men on alprostadil, per Endocrine Society guidance [7], since declining testosterone can reduce alprostadil's effectiveness.

Cost Expectations and Discount Programs

Out-of-pocket costs for Wyoming patients without insurance coverage fall into three tiers.

Branded Caverject (6-pack, 10 mcg): approximately $380, $510 at Wyoming retail pharmacies. MUSE 10-suppository pack (500 mcg): approximately $300, $420. Compounded alprostadil (10 mL vial at 20 mcg/mL from a 503A pharmacy): approximately $120, $180, covering roughly 20 doses at the median effective dose.

GoodRx and Blink Health discount cards reduce branded Caverject pricing at Walmart and Walgreens in Wyoming by 15 to 30%. Pfizer does not currently offer a branded patient assistance program for Caverject specifically for commercially insured patients, but the NeedyMeds database lists state-level Wyoming pharmacy assistance programs that may partially offset cost [18].

The telehealth consultation itself typically runs $75, $150 for an initial visit; follow-up dose-titration visits average $50, $75. Wyoming's telehealth parity law may require your insurer to reimburse the consultation at in-network rates [6].

What to Expect at Your First Appointment

The first telehealth visit for alprostadil in Wyoming runs 20 to 30 minutes and covers five areas: sexual history (onset, severity, situational vs. global ED), cardiovascular and metabolic review, medication reconciliation (especially nitrates, alpha-blockers, anticoagulants), lab review, and dose selection.

Bring your most recent lab results if available. If labs are not current, the provider will order them electronically and can issue a conditional prescription that releases to the pharmacy once labs return within acceptable ranges. Most lab panels return within 24 to 48 hours through national chains such as LabCorp or Quest, which have draw sites in Cheyenne (5 locations), Casper (3 locations), Laramie (2 locations), and Gillette (2 locations).

After the visit, the pharmacy ships to your Wyoming address. Delivery to Cheyenne, Casper, and Laramie typically takes 2, 3 business days via standard shipping; rural ZIP codes in Teton or Sublette County may take 4, 7 business days depending on the pharmacy's carrier network. A starting dose of Caverject 2.5 mcg with the first injection completed at a local urgent care or your primary care office brings total time to first at-home use to approximately 5 to 10 days from your telehealth visit.